A detailed history of Gamma Investing LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 3,173 shares of MRNA stock, worth $103,439. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,173
Previous 2,405 31.93%
Holding current value
$103,439
Previous $161 Million 17.91%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$36.85 - $63.93 $28,300 - $49,098
768 Added 31.93%
3,173 $132 Million
Q3 2024

Oct 04, 2024

SELL
$63.64 - $125.14 $123,143 - $242,145
-1,935 Reduced 44.59%
2,405 $161 Million
Q2 2024

Jul 02, 2024

BUY
$101.21 - $166.61 $136,228 - $224,257
1,346 Added 44.96%
4,340 $515 Million
Q1 2024

Apr 05, 2024

BUY
$85.37 - $115.44 $70,174 - $94,891
822 Added 37.85%
2,994 $319 Million
Q4 2023

Feb 01, 2024

BUY
$69.51 - $104.43 $150,975 - $226,821
2,172 New
2,172 $219 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.